Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: The IGLOO (impaired glucose tolerance and long-term outcomes observational) study

Diabetes Care

Volumn 28, Issue 5, 2005, Pages 1187-1194

  Franciosi, Monica ^a   De Berardis, Giorgia ^a   Rossi, Maria C E ^a   Sacco, Michele ^a   Belfiglio, Maurizio ^a   Pellegrini, Fabio ^a   Tognoni, Gianni ^a   Valentini, Miriam ^a   Nicolucci, Antonio ^a,b  

^a Consorzio Mario Negri Sud ^*  (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; FEMALE; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCREENING; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS;

EID: 18144425460     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.5.1187     Document Type: Article

References (22)

1. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431, 1998
2. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16: 642-652, 1993
3. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21:518-524, 1998
4. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544, 1997
5. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, the Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
6. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, the Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
7. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, the STOP-NIDDM Trail Research Group: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072-2077, 2002
8. Paterson KR: Population screening for diabetes mellitus: Professional Advisory Committee of the British Diabetic Association. Diabet Med 10:777-781, 1993
9. Lindström J, Tuomilehto J: The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725-731, 2003
10. National Institutes of Health: Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults (Adult Treatment Panel III): Executive Summary. Bethesda, MD, National Institute of Health, National Heart, Lung and Blood Institute, 2001 (NIH publ. no. 01-3670)
11. Simel DL, Samsa GP, Matchar DB: Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 44:763-770, 1991
12. Sackett DL, Haynes RB, Tugwell P: Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston, MA, Little, Brown & Company, 1986
13. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part I: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999
14. American Diabetes Association: Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 27 (Suppl. 1):S5-S10, 2004
15. Baan CA, Ruige JB, Stolk RP, Witteman JC, Dekker JM, Heine RJ, Feskens EJ: Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care 22:213-219, 1999
16. Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE: A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 18:382-387, 1995
17. Tabaei BP, Herman WH: A multivariate logistic regression equation to screen for diabetes: development and validation. Diabetes Care 25:1999-2003, 2002
18. Barriga KJ, Hamman RF, Hoag S, Marshall JA, Shetterly SM: Population screening for glucose intolerant subjects using decision tree analyses. Diabetes Res Clin Pract 34 (Suppl.):S17-S29, 1996
19. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ: Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabete Metab Res Res 16:164-171, 2000
20. Glümer C, Carstensen B, Sandbæk A, Lauritzen T, Jørgensen T, Borch-Johnsen K: A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 27:727-733, 2004
21. Schmidt MI, Duncan BB, Vigo A, Pankow J, Ballantyne CM, Couper D, Brancati F, Folsom AR, ARIC Investigators: Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities Study. Diabetes Care 26: 1338-43, 2003
22. Rolka DB, Narayan KM, Thompson TJ, Goldman D, Lindenmayer J, Alich K, Bacall D, Benjamin EM, Lamb B, Stuart DO, Engelgau MM: Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care 24:1899-1903, 2001